Targeting the Epidermal Growth Factor Receptor in EGFR-Mutated Lung Cancer: Current and Emerging Therapies

SIMPLE SUMMARY: Epidermal growth factor receptor (EGFR) mutations occur in a significant number of lung cancer patients. Treatment outcomes in this subset of patients has greatly improved over the last decade after the introduction of EGFR tyrosine kinase inhibitors (TKIs), which demonstrated high e...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Cancers (Basel)
Главные авторы: Khaddour, Karam, Jonna, Sushma, Deneka, Alexander, Patel, Jyoti D., Abazeed, Mohamed E., Golemis, Erica, Borghaei, Hossein, Boumber, Yanis
Формат: Artigo
Язык:Inglês
Опубликовано: MDPI 2021
Предметы:
Review
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC8267708/
https://ncbi.nlm.nih.gov/pubmed/34202748
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13133164
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы